Differential cytokine and chemokine production characterizes experimental autoimmune meningitis and experimental autoimmune encephalomyelitis

Clinical Immunology

Volumn 94, Issue 2, 2000, Pages 114-124

  Perrin, Peter J ^a   Rumbley, Catherine A ^a   Beswick, Richard L ^a   Lavi, Ehud ^a   Phillips, S Michael ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CD28; Encephalomyelitis; IL 2; IL 6; Meningitis

Indexed keywords

CD28 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN; INTERLEUKIN 2; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE MENINGITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; IMMUNIZATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL;

EID: 0033972431     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4825     Document Type: Article

References (41)

1. June C. H., Bluestone J. A., Nadler L. M., Thompson C. B. The B7 and CD28 receptor families. Immunol. Today. 15:1994;321-331.
2. Schwartz R. H. A cell culture model for T lymphocyte clonal anergy. Science. 258:1990;1349-1352.
3. Boise L. H., Minn A. J., Noel P. J., June C. H., Accavitti M. A., Lindsten T., Thompson C. B. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity. 3:1995;87-98.
4. Freeman G. J., Boussiotis V. A., Anumanthan A., Bernstein G. M., Ke X. Y., Rennert P. D., Gray G. S., Gribben J. G., Nadler L. M. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity. 2:1995;523-532.
5. Freeman G. J., Borriello F., Hodes R. J., Reiser H., Gribben J. G., Ng J. W., Kim J., Goldberg J. M., Hathcock K., Laszlo G. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178:1993;2185-2192.
6. Freeman G. J., Borriello F., Hodes R. J., Reiser H., Hathcock K. S., Laszlo G., McKnight A. J., Kim J., Du L., Lombard D. B. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science. 262:1993;907-909.
7. Perrin P. J., Lavi E., Zekavat S. A., Rumbley C. A., Phillips S. M. Experimental autoimmune meningitis: A novel neurological disease in CD28 deficient mice. Clin. Immunol. 91:1999;41-49.
8. Tyler K. L. Aspetic menigitis, viral encepalitis, and prion diseases. Fauci A. S., Braunwald E., Isselbacher K. J., Wilson J. D., Martin J. B., Kasper D. L., Hauser S. L., Longo D. L., Harrison's Principles of Internal Medicine. 1998;2439-2451 McGraw-Hill, Columbus.
9. Mendel I., Kerlero d. R., Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: Fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25:1995;1951-1959.
10. Swanborg R. H. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin. Immunol. Immunopathol. 77:1995;4-13.
11. Steinman L. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: A tale of smart bombs and the infantry. Proc. Natl. Acad. Sci. USA. 93:1996;2253-2256.
12. Zinkernagel R. M., Ehl S., Aichele P., Oehen S., Kundig T., Hengartner H. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: A geographical view of immune reactivity. Immunol. Rev. 156:1997;199-209.
13. Mendel I., Kerlero de Rosbo N., Ben-Nun A. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: Diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice. Eur. J. Immunol. 26:1996;2470-2479.
14. Cohen J. A., Essayan D. M., Zweiman B., Lisak R. P. Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis. Cell. Immunol. 108:1987;203-213.
15. Rumbley C. A., Sugaya H., Zekavat S. A., ElRefaei M., Perrin P. J., Phillips S. M. Activated eosinophils are the major source of Th-2 associated cytokines in the schistosome granuloma. J. Immunol. 162:1999;1003-1009.
16. Nelson B. H., Willerford D. M. Biology of the interleukin-2 receptor. Adv. Immunol. 70:1998;1-81.
17. Krakowski M., Owens T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1996;1641-1646.
18. Chen Y., Kuchroo V. K., Inobe J., Hafler D. A., Weiner H. L. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
19. Hafler D. A., Kent S. C., Pietrusewicz M. J., Khoury S. J., Weiner H. L., Fukaura H. Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis. Ann. N. Y. Acad. Sci. 835:1997;120-131.
20. Eugster H. P., Frei K., Kopf M., Lassmann H., Fontana A. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:1998;2178-2187.
21. Mendel I., Katz A., Kozak N., Ben-Nun A., Revel M. Interleukin-6 functions in autoimmune encephalomyelitis: A study in gene-targeted mice. Eur. J. Immunol. 28:1998;1727-1737.
22. Samoilova E. B., Horton J. L., Hilliard B., Liu T. S., Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:1998;6480-6486.
23. Gijbels K., Brocke S., Abrams J. S., Steinman L. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol. Med. 1:1995;795-805.
24. Shahinian A., Pfeffer K., Lee K. P., Kundig T. M., Kishihara K., Wakeham A., Kawai K., Ohashi P. S., Thompson C. B., Mak T. W. Differential T cell costimulatory requirements in CD28-deficient mice. Science. 261:1993;609-612.
25. Mittrucker H. W., Shahinian A., Bouchard D., Kundig T. M., Mak T. W. Induction of unresponsiveness and impaired T cell expansion by staphylococcal enterotoxin B in CD28-deficient mice. J. Exp. Med. 183:1996;2481-2488.
26. Saha B., Harlan D. M., Lee K. P., June C. H., Abe R. Protection against lethal toxic shock by targeted disruption of the CD28 gene. J. Exp. Med. 183:1996;2675-2680.
27. Shanafelt M. C., Soderberg C., Allsup A., Adelman D., Peltz G., Lahesmaa R. Costimulatory signals can selectively modulate cytokine production by subsets of CD4+ T cells. J. Immunol. 154:1995;1684-1690.
28. Lenschow D. J., Walunas T. L., Bluestone J. A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:1996;233-258.
29. Thompson C. B. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell. 81:1995;979-982.
30. Tao X., Constant S., Jorritsma P., Bottomly K. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation. J. Immunol. 159:1997;5956-5963.
31. Perrin P. J., Scott D., Quigley L., Albert P. S., Feder O., Gray G. S., Abe R., June C. H., Racke M. K. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunol. 154:1995;1481-1490.
32. Gause W. C., Chen S. J., Greenwald R. J., Halvorson M. J., Lu P., Zhou X. D., Morris S. C., Lee K. P., June C. H., Finkelman F. D., Urban J. F., Abe R. CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J. Immunol. 158:1997;4082-4087.
33. Bachmaier K., Pummerer C., Shahinian A., Ionescu J., Neu N., Mak T. W., Penninger J. M. Induction of autoimmunity in the absence of CD28 costimulation. J. Immunol. 157:1996;1752-1757.
34. Brach M. A., Herrmann F. Interleukin 6: Presence and future. Int. J. Clin. Lab. Res. 22:1992;143-151.
35. Meda L., Baron P., Prat E., Scarpini E., Scarlato G., Cassatella M. A., Rossi F. Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid [25-35]. J. Neuroimmunol. 93:1999;45-52.
36. Lecoanet-Henchoz S., Plater-Zyberk C., Graber P., Gretener D., Aubry J. P., Conrad D. H., Bonnefoy J. Y. Mouse CD23 regulates monocyte activation through an interaction with the adhesion molecule CD11b/CD18. Eur. J. Immunol. 27:1997;2290-2294.
37. Gadient R. A., Otten U. Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci. Lett. 182:1994;243-246.
38. Sonoda Y., Mukaida N., Wang J. B., Shimada-Hiratsuka M., Naito M., Kasahara T., Harada A., Inoue M., Matsushima K. Physiologic regulation of postovulatory neutrophil migration into vagina in mice by a C-X-C chemokine(s). J. Immunol. 160:1998;6159-6165.
39. Herold K. C., Lu J., Rulifson I., Vezys V., Taub D., Grusby M. J., Bluestone J. A. Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation. J. Immunol. 159:1997;4150-4153.
40. Taub D. D. Chemokine-leukocyte interactions. Cytokine Growth Factor Rev. 7:1996;355-376.
41. Eng L. F., Ghirnikar R. S., Lee Y. L. Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem. Res. 21:1996;511-525.